Literature DB >> 15158066

The effect of sample degradation and RNA stabilization on classical swine fever virus RT-PCR and ELISA methods.

Stuart D Blacksell1, Syseng Khounsy, Harvey A Westbury.   

Abstract

Classical swine fever (CSF), also known as hog cholera, is a highly contagious viral infection of swine caused by a member of the genus pestivirus of the family, Flaviviridae. The need for accurate laboratory diagnosis of CSF is particularly important as it is more reliable than clinical diagnosis. CSF is endemic in many tropical countries where the climate is characterized by high ambient temperature and humidity. This study details the effect of sample quality on CSF antigen-capture ELISA (AC-ELISA) and reverse transcriptase-polymerase chain reaction (RT-PCR) methods. RT-PCR assessment of AC-ELISA-positive spleen samples stored in a conventional glycerol/saline buffer demonstrated that the RT-PCR was detrimentally affected by poor sample quality. To provide a more accurate representation of this effect, a 14 days study was performed to determine the effect of tropical ambient conditions on CSF virus-positive spleen samples stored in two transport media; glycerol/saline and a proprietary RNA preservation solution (RNAlater). A protective effect was demonstrated in both assays with RNAlater as samples were positive in both assays until day 14 post-exposure. Samples stored in glycerol/saline were negative at RT-PCR at day 3 post-exposure although AC-ELISA was still positive at day 14 post-exposure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158066     DOI: 10.1016/j.jviromet.2004.01.015

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

1.  Diagnosis of classical swine fever virus in a limited resource setting: the influence of pig breed on methodology and sample selection.

Authors:  S Khounsy; L J Gleeson; D Van Aken; H A Westbury; S D Blacksell
Journal:  Trop Anim Health Prod       Date:  2007-01       Impact factor: 1.559

2.  Development and evaluation of a rapid immunomagnetic bead assay for the detection of classical swine fever virus antigen.

Authors:  James V Conlan; Syseng Khounsy; Stuart D Blacksell; Christopher J Morrissy; Colin R Wilks; Laurence J Gleeson
Journal:  Trop Anim Health Prod       Date:  2008-11-29       Impact factor: 1.559

3.  Genetic typing of classical swine fever viruses from Lao PDR by analysis of the 5' non-coding region.

Authors:  Stuart D Blacksell; Syseng Khounsy; David B Boyle; Laurence J Gleeson; Harvey A Westbury; John S Mackenzie
Journal:  Virus Genes       Date:  2005-12       Impact factor: 2.332

4.  A unified sample preparation protocol for proteomic and genomic profiling of cervical swabs to identify biomarkers for cervical cancer screening.

Authors:  Janet S Rader; James P Malone; Julia Gross; Petra Gilmore; Rebecca A Brooks; Loan Nguyen; Dan L Crimmins; Sheng Feng; Jason D Wright; Nicholas Taylor; Israel Zighelboim; Margo C Funk; Phyllis C Huettner; Jack H Ladenson; David Gius; R Reid Townsend
Journal:  Proteomics Clin Appl       Date:  2008-10-22       Impact factor: 3.494

5.  Multiplex 16S rRNA-derived geno-biochip for detection of 16 bacterial pathogens from contaminated foods.

Authors:  Hwa Hui Shin; Byeong Hee Hwang; Hyung Joon Cha
Journal:  Biotechnol J       Date:  2016-09-06       Impact factor: 4.677

6.  Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001-2003.

Authors:  Pierre Rouquet; Jean-Marc Froment; Magdalena Bermejo; Annelisa Kilbourn; William Karesh; Patricia Reed; Brice Kumulungui; Philippe Yaba; André Délicat; Pierre E Rollin; Eric M Leroy
Journal:  Emerg Infect Dis       Date:  2005-02       Impact factor: 6.883

7.  Evaluation of Fast Technology Analysis (FTA) Cards as an improved method for specimen collection and shipment targeting viruses associated with Bovine Respiratory Disease Complex.

Authors:  Xiao Liang; Munashe Chigerwe; Sharon K Hietala; Beate M Crossley
Journal:  J Virol Methods       Date:  2014-03-20       Impact factor: 2.014

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.